230 related articles for article (PubMed ID: 22894970)
1. Overview of cancer vaccines: considerations for development.
Kudrin A
Hum Vaccin Immunother; 2012 Sep; 8(9):1335-53. PubMed ID: 22894970
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: what do we need to measure in clinical trials?
Kudrin A
Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
[TBL] [Abstract][Full Text] [Related]
3. Overview of the cancer vaccine field: are we moving forward?
Kudrin A; Hanna MG
Hum Vaccin Immunother; 2012 Aug; 8(8):1135-40. PubMed ID: 22854670
[TBL] [Abstract][Full Text] [Related]
4. RNA vaccines in cancer treatment.
Bringmann A; Held SA; Heine A; Brossart P
J Biomed Biotechnol; 2010; 2010():623687. PubMed ID: 20625504
[TBL] [Abstract][Full Text] [Related]
5. Cancer vaccines as promising immuno-therapeutics: platforms and current progress.
Liu J; Fu M; Wang M; Wan D; Wei Y; Wei X
J Hematol Oncol; 2022 Mar; 15(1):28. PubMed ID: 35303904
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in therapeutic cancer vaccines.
Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
[TBL] [Abstract][Full Text] [Related]
7. Neoantigen: A New Breakthrough in Tumor Immunotherapy.
Zhang Z; Lu M; Qin Y; Gao W; Tao L; Su W; Zhong J
Front Immunol; 2021; 12():672356. PubMed ID: 33936118
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell-based immunotherapy.
Osada T; Clay TM; Woo CY; Morse MA; Lyerly HK
Int Rev Immunol; 2006; 25(5-6):377-413. PubMed ID: 17169781
[TBL] [Abstract][Full Text] [Related]
9. Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.
Garg AD; Coulie PG; Van den Eynde BJ; Agostinis P
Trends Immunol; 2017 Aug; 38(8):577-593. PubMed ID: 28610825
[TBL] [Abstract][Full Text] [Related]
10. Next generation approaches for tumor vaccination.
Patel A; Kaufman HL; Disis ML
Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
[TBL] [Abstract][Full Text] [Related]
11. Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.
Spagnoli GC; Ebrahimi M; Iezzi G; Mengus C; Zajac P
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):184-92. PubMed ID: 20205052
[TBL] [Abstract][Full Text] [Related]
12. Combination therapies utilizing neoepitope-targeted vaccines.
Lee KL; Schlom J; Hamilton DH
Cancer Immunol Immunother; 2021 Apr; 70(4):875-885. PubMed ID: 33033852
[TBL] [Abstract][Full Text] [Related]
13. Translating tumor antigens into cancer vaccines.
Buonaguro L; Petrizzo A; Tornesello ML; Buonaguro FM
Clin Vaccine Immunol; 2011 Jan; 18(1):23-34. PubMed ID: 21048000
[TBL] [Abstract][Full Text] [Related]
14. Challenges for cancer vaccine development.
Tabi Z; Man S
Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
[TBL] [Abstract][Full Text] [Related]
15. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
Gjerstorff MF; Burns J; Ditzel HJ
Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
[TBL] [Abstract][Full Text] [Related]
16. Vaccines and immunotherapeutics for the treatment of malignant disease.
Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Kennedy RC
Clin Dev Immunol; 2010; 2010():697158. PubMed ID: 20936120
[TBL] [Abstract][Full Text] [Related]
17. Technical challenges facing therapeutic cancer vaccines.
Ward S; Copier J; Dalgleish A
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):168-77. PubMed ID: 18283604
[TBL] [Abstract][Full Text] [Related]
18. Composite peptide-based vaccines for cancer immunotherapy (Review).
Yang J; Zhang Q; Li K; Yin H; Zheng JN
Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
[TBL] [Abstract][Full Text] [Related]
19. Whole cell vaccines--past progress and future strategies.
Keenan BP; Jaffee EM
Semin Oncol; 2012 Jun; 39(3):276-86. PubMed ID: 22595050
[TBL] [Abstract][Full Text] [Related]
20. Cancer vaccines.
Liu MA
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2823-6. PubMed ID: 21893546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
